PARP1 and Familial prostate cancer: To determine whether this finding is also true in prostate cancer cells, DU-145 transfectants were treated with increasing doses of pro-apoptotic drugs and analyzed for cleavage of Parp-1, which is a commonly used marker of apoptosis [34].